Table 1 Baseline demographic and clinical characteristics.

From: A novel index evaluating left atrioventricular coupling function in chronic kidney disease with diabetes patients

 

CKD-DM(n = 110)

CKD + DM(n = 66)

t/z/X2

p

Age

36(28,48)

59(52,67)

-8.773

<0.001

Gender

  

7.023

0.008

 Female (%)

44.9

25.3

  

 Male (%)

55.1

74.7

  

BMI

21.69(19.94,24.37)

23.66(22.32,25.24)

-3.670

<0.001

Body surface area

1.63 ± 0.20

1.70 ± 0.16

-2.683

0.008

Hypertension (%)

71.4

90.7

9.743

0.002

 Smoking (%)

17.3

52.0

23.305

< 0.001

 Drinking (%)

17.4

41.3

12.193

0.001

 SBP (mmHg)

144.6 ± 24.1

151.0 ± 20.5

-1.847

0.066

 DBP (mmHg)

93(82,105)

84(74,92)

-3.879

< 0.001

Troponin T (ng/ml)

0.027(0.017,0.064)

0.047(0.026,0.108)

-3.361

0.001

Myoglobin (ng/ml)

143.7(99.3,222.7)

146.7(81.8,266.8)

-0.057

0.955

NT-proBNP (pg/ml)

2279(652,12516)

9722(3231,31763)

-3.991

< 0.001

CKD stage (%)

  

1.284

0.257

 CKD4 stage

45.9

37.3

  

 CKD5 stage

54.1

62.7

  

Dialysis (%)

65.3

53.3

2.540

0.111

Urea (mmol/L)

14.42(7.52,22.29)

15.50(10.30,21.74)

-1.947

0.052

Creatinine (umol/L)

500.8(137.5,826.5)

462.5(215.9,876.5)

-0.829

0.407

Uric acid (umol/L)

448(323,540)

403(338,490)

-1.913

0.056

Blood glucose (umol/L)

5.33(4.67,6.48)

7.27(6.10,9.12)

-5.247

< 0.001

Cystatin C (mg/L)

4.26(1.86,6.11)

4.10(2.84,5.52)

-1.622

0.105